World's Best Scientists 2026 revealed!
Ben A. C. Dijkmans

Ben A. C. Dijkmans

D-Index & Metrics

Medicine

D-Index
110
Citations
51222
World Ranking
5499
National Ranking
207

Overview

Ben A. C. Dijkmans is affiliated with Amsterdam UMC in the Netherlands. This association situates them within a research university medical center environment, likely contributing to clinical or biomedical academic work. The profile presents no data on specific research papers, fields of study, or topics linked to their name.

There are no recorded recent papers, frequent co-authors, or common publication venues associated with Ben A. C. Dijkmans in the available data. Similarly, there is no information on book publications or distinct academic fields, subfields, or main topics of study related to their research.

No awards or honors have been listed, and the available data confirms that Ben A. C. Dijkmans is currently living. The limited information suggests that the profile is focused solely on the professional affiliation without further detail on research output or scientific contributions.

Best Publications

  • The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy

    Dougados M;van der Linden S;Juhlin R;Huitfeldt B

  • Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors

    Markus M. J. Nielen;Dirkjan van Schaardenburg;Henk W. Reesink;Rob J. van de Stadt

  • EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

    M J Peters;D P M Symmons;D McCarey;B A Dijkmans

  • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

    Y. P. M. Goekoop-Ruiterman;J. K. De Vries-Bouwstra;C. F. Allaart;D. Van Zeben

  • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

    Maarten Boers;Arco C Verhoeven;Harry M Markusse;Mart Afj van de Laar

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal

    M Rudwaleit;R Landewé;D van der Heijde;J Listing

  • Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

    Désirée van der Heijde;Alan Kivitz;Michael H. Schiff;Joachim Sieper

  • Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).

    Désirée van der Heijde;Ben Dijkmans;Piet Geusens;Joachim Sieper

  • ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Zochling;D. Van Der Heijde;R. Burgos-Vargas;E. Collantes

  • Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up.

    Geertje M. Bartelds;Charlotte L. M. Krieckaert;Michael T. Nurmohamed;Pauline A. van Schouwenburg

  • COBRA Combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention

    Robert B. M. Landewé;Maarten Boers;Arco C. Verhoeven;Rene Westhovens

  • New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)

    J. Sieper;D.M. Van der Heijde;RB Landewe;J. Brandt

  • Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis

    Geertje M Bartelds;Carla A Wijbrandts;Michael T Nurmohamed;Steven Stapel

  • Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

    Gerrit Jan Wolbink;Marijn Vis;Willem Lems;Alexandre E. Voskuyl

  • Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.

    Yvonne P M Goekoop-Ruiterman;Jeska K de Vries-Bouwstra;Cornelia F Allaart;Derkjen van Zeben

  • Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein

    Ruud Oerlemans;Niels E. Franke;Yehuda G. Assaraf;Jacqueline Cloos

  • Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission.

    Esmeralda T. H. Molenaar;Alexandre E. Voskuyl;Huib J. Dinant;P. Dick Bezemer

  • Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

    A E van Ede;R F Laan;M J Rood;T W Huizinga

  • Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

    Mike J. Peters;Irene E. van der Horst-Bruinsma;Ben A. Dijkmans;Michael T. Nurmohamed

Frequent Co-Authors

Willem F. Lems
Willem F. Lems Vrije Universiteit Amsterdam
Michael T. Nurmohamed
Michael T. Nurmohamed University of Amsterdam
Ferdinand C. Breedveld
Ferdinand C. Breedveld Leiden University Medical Center
Jan P. Vandenbroucke
Jan P. Vandenbroucke Leiden University Medical Center
Maarten Boers
Maarten Boers Vrije Universiteit Amsterdam
Gerrit Jansen
Gerrit Jansen Amsterdam UMC
Rik J. Scheper
Rik J. Scheper Amsterdam University Medical Centers
Robert Landewé
Robert Landewé University of Amsterdam
Paul P. Tak
Paul P. Tak GlaxoSmithKline (United Kingdom)
Erik J. Giltay
Erik J. Giltay Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative medical career pathways can provide flexibility, affordability, and quicker access to the healthcare workforce. For those looking to enter nursing rapidly, learning what is the fastest way to become an lpn can be a great starting point. Many choose this path to gain hands-on experience sooner and begin working in patient care.

If you are interested in advanced practice and mental health, there are programs designed for speed and specialization. Discover your options with accelerated msn psychiatric np programs, which can help qualified nurses quickly transition into mental health roles.

Not all careers in medicine require direct patient interaction. You might consider the administrative side by researching healthcare administration degrees. These online programs are ideal for those interested in leadership and management roles within healthcare organizations.

Affordability is a common concern. Understanding mha degree cost can help you make informed decisions regarding your education and manage tuition expenses more effectively.

Best Scientists Citing Ben A. C. Dijkmans

Trending Scientists

Recently Published Articles